News

CELLF BIO Achieves Milestone With First In Human Implantation of BioSphincter™

CELLF BIO achieved a major milestone with the world’s first human implantation of BioSphincter™, an autologous bioengineered sphincter made of smooth muscle and differentiated neural stem cells. The Phase 1 clinical trial is being conducted to treat patients with fecal incontinence (FI), a condition that affects millions of people worldwide. The implantation surgery was performed by Dr. Jaime Bohl, chief of colon and rectal surgery at the Virginia Commonwealth University School of Medicine in Richmond, Virginia.

“We are very pleased with the progress of the clinical trial thus far,” said CELLF BIO CEO Dr. Khalil N. Bitar, PhD, AGAF. “The implantation was successfully completed and the patient is doing well. This is a major step forward in the development of BioSphincter™ as a potential treatment for FI.”

FI is a debilitating condition that can cause great embarrassment and social isolation. Current treatments for FI are often ineffective and can have serious side effects. BioSphincter™ offers a potential solution for FI sufferers who have not responded to other treatments.

The BioSphincter™ is made from the patient’s own cells, which are harvested from intestinal biopsies and then cultured in the laboratory. Once the cells are ready, they are bioengineered into rings and implanted into the patient’s anal sphincter, where they will begin to function as a normal internal Anal Sphincter.

The clinical trial is expected to continue for several more months, and CELLF BIO is hopeful that BioSphincter will ultimately be approved for use in patients with FI in the future.

“If successful, BioSphincter could provide a much-needed treatment option for patients with FI,” said Dr. Bitar. “We are committed to continuing the development of this potentially life-changing therapy.”

The BioSphincter™ clinical trial is currently funded by a grant from NIH and the company is looking to raise capital to support next steps in commercialization.

Learn more here.

Recent News

09/22/2023

State public health laboratory, Henrico County Schools launch pilot program to promote life science career

More than 50 Henrico County high school students and teachers joined scientists from Virginia’s public health and environmental laboratory Wednesday to kick off an innovative program that brings together private and government scientists and experts, business and nonprofit leaders, and public schools to explore ways to create a pipeline of talent to fuel Virginia’s growing

09/21/2023

Climate Tech Startup ThermaGEL Innovations’ Breakthrough Aerogels Join the Challenge to Save Half-Gigaton of C02 Emissions Each Year

In the fight against climate change, properly insulating homes and buildings can significantly raise energy efficiency and indoor air quality while lowering carbon dioxide emissions. A startup company, spun out of research at Virginia Commonwealth University, is commercializing what it calls a breakthrough in low-cost insulation materials. ThermaGEL Innovations has developed insulation material using aerogels,

09/20/2023

Charlottesville healthy sugar innovator Bonumose raises $2M

Bonumose Inc., a Charlottesville startup specializing in table sugar alternatives, has raised $2 million toward a $10 million funding round after German flavor and fragrances producer Symrise AG signed a minority investment agreement with the company. “The strategic investment from Symrise is part of a larger funding round that will be used for increasing sales,